Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.
about
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesFourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusNon-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and DexamethasoneHow I treat influenza in patients with hematologic malignancies.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsParainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomesParainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic reviewManagement of respiratory viral infections in hematopoietic cell transplant recipients.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationFebrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignanciesMortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation.BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus.Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.Respiratory syncytial virus infection in older adults: an under-recognized problem.Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Prolonged respiratory viral shedding in transplant patients.Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Respiratory Viruses in Febrile Neutropenic Patients with Respiratory Symptoms.A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
P2860
Q26829188-1B675A2D-BF2F-4B19-9286-CF63B8ED423BQ26853131-253C423C-B194-4E6A-B140-73C8450A7C70Q27021622-93A4C45B-1C35-49C6-95E5-4641CE23DBB9Q27312086-09389D47-9B03-4E6C-BE56-3A075B3484A5Q30383456-1BFC5E0A-8A86-45B7-A82D-251991D8C34AQ30403699-D1AA0F9B-22E7-46D3-BB10-3E199C33610FQ33714717-800A8B82-9CEB-4EE6-8CFF-57BB59E8B3A9Q35095639-D4060155-1DE9-4A4F-B15F-0394C753A273Q36386176-FC963B04-909A-4039-B8B2-B2D8FAC136E0Q36439896-CF35CC2B-36E9-4265-B6F9-176BA1626CAAQ36965855-A43FB467-A6A2-4DB6-A1EE-5F7230670D51Q36996637-F2A0A8D8-20DF-4EE5-92C2-136971C5A01FQ37118406-EBC8BD25-CE0C-4772-A555-9B589584832DQ37671949-79047A74-2A72-4447-8203-AA3A63260528Q37991125-C8EEBBD9-6FF4-4B8D-8AE2-4727419684A5Q38013661-CEF3B95D-65E4-4250-9745-AE186D3AE79AQ38077827-3DF459AA-DBFE-4A72-A800-A0904ACAB418Q39038875-85E9456F-B89A-4204-A76D-29B33F723983Q39118448-6C725374-93B2-4234-A3B6-D74E8D373F00Q40673394-50F7FE24-0091-455B-A1F3-3214E1210FAFQ40721939-F8A03CF0-DD47-46FF-90B0-29F0F0600EC2Q41001772-99D8B2DA-0567-44CA-8B12-8AE831B89296Q41166298-8724BE56-D921-4716-B9BC-E83F0728AA36Q41349182-E1DCC693-9E56-4B44-8008-B99A93FD47C1Q41927260-85FC1707-473F-48B9-B32F-64D19FCC63A3Q42238692-A961530F-6CFA-4129-A34E-E88303B0C562Q42262215-AD9AA5CB-DB79-4834-844A-E03764772FC8Q47312420-0F7DE0D6-1D61-480B-9E82-2ADE970B3F4FQ49866109-1F09530C-F44A-4D8D-B018-F75D8AFE202CQ50557432-AEFC2C3A-723C-4008-B40F-60D1F00D31ADQ54204894-ED0AB2C8-7D77-4B79-A40B-28967F4E82F2
P2860
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Timing and severity of communi ...... tic stem cell transplantation.
@en
Timing and severity of communi ...... tic stem cell transplantation.
@nl
type
label
Timing and severity of communi ...... tic stem cell transplantation.
@en
Timing and severity of communi ...... tic stem cell transplantation.
@nl
prefLabel
Timing and severity of communi ...... tic stem cell transplantation.
@en
Timing and severity of communi ...... tic stem cell transplantation.
@nl
P2860
P50
P1433
P1476
Timing and severity of communi ...... tic stem cell transplantation.
@en
P2093
Joshua T Schiffer
Kate Kirby
P2860
P304
P356
10.3324/HAEMATOL.2008.003186
P577
2009-08-01T00:00:00Z